Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Scott T. Micek"'
Autor:
Hayley Motowski, MD, Daniel Ilges, PharmD, Nicholas Hampton, PharmD, Marin H. Kollef, MD, Scott T. Micek, PharmD
Publikováno v:
Critical Care Explorations, Vol 5, Iss 3, p e0867 (2023)
IMPORTANCE:. Hospital-acquired pneumonia (HAP) is the most common hospital-acquired infection, accounting for 22% of all nosocomial infections. The available studies to date have not attempted to assess whether confounding factors may account for the
Externí odkaz:
https://doaj.org/article/046c7f01855b421eac73e6f27e45a5a7
Autor:
Marin H. Kollef, Andrew F. Shorr, Matteo Bassetti, Jean-Francois Timsit, Scott T. Micek, Andrew P. Michelson, Jose Garnacho-Montero
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-10 (2021)
Abstract Severe or life threatening infections are common among patients in the intensive care unit (ICU). Most infections in the ICU are bacterial or fungal in origin and require antimicrobial therapy for clinical resolution. Antibiotics are the cor
Externí odkaz:
https://doaj.org/article/917bc16420fc474f9a1d9d1c0abe9634
Autor:
Daniel Reynolds, Jason P. Burnham, Cristina Vazquez Guillamet, Mikaela McCabe, Valerie Yuenger, Kevin Betthauser, Scott T. Micek, Marin H. Kollef
Publikováno v:
European Respiratory Review, Vol 31, Iss 166 (2022)
Antibiotic resistance is recognised as a global threat to human health by national healthcare agencies, governments and medical societies, as well as the World Health Organization. Increasing resistance to available antimicrobial agents is of concern
Externí odkaz:
https://doaj.org/article/211bb8f5228d4ce98fb89eb77e29ea5a
Autor:
Thomas J. Dilworth, PharmD, Lucas T. Schulz, PharmD, Scott T. Micek, PharmD, Marin H. Kollef, MD, Warren E. Rose, PharmD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 7, p e0726 (2022)
OBJECTIVE:. β-lactams are the cornerstone of empiric and targeted antibiotic therapy for critically ill patients. Recently, there have been calls to use β-lactam therapeutic drug monitoring (TDM) within 24–48 hours after the initiation of therapy
Externí odkaz:
https://doaj.org/article/dbec365f4e5b4cd384caeda2d220cd69
Autor:
Richard F. Van Besien, MD, Nicholas Hampton, PharmD, Scott T. Micek, PharmD, Marin H. Kollef, MD, Maya Saranathan.
Publikováno v:
Medicine, Vol 101, Iss 20, p e29159 (2022)
Abstract. Much remains unknown about the impact of initial antibiotic adequacy on mortality in community onset bacterial pneumonia (COBP). Therefore, we performed a study to determine how the adequacy of initial antibiotic therapy affects in-hospital
Externí odkaz:
https://doaj.org/article/99dad2aad0024131912c88e49e799173
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Externí odkaz:
https://doaj.org/article/7983efde679d49419efe10c417252fb3
Publikováno v:
Critical Care, Vol 21, Iss 1, Pp 1-8 (2017)
Abstract Background Antibiotics are commonly administered to hospitalized patients with infiltrates for possible bacterial pneumonia, often leading to unnecessary treatment and increasing the risk for resistance emergence. Therefore, we performed a s
Externí odkaz:
https://doaj.org/article/dcb55317ce7043f6aae56d3365c8e1a5
Autor:
Christopher A. Jones, Kevin D. Betthauser, Bryan D. Lizza, Paul A. Juang, Scott T. Micek, Marin H. Kollef
Publikováno v:
Hospital pharmacy. 57(4)
Purpose: Recent data highlight unclear efficacy and potential negative sequelae of stress ulcer prophylaxis (SUP) in the intensive care unit (ICU). Minimizing SUP exposure has pertinent clinical and other implications. This study assessed medication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a1a9e51c594237dbacdefa2be3f354
https://pubmed.ncbi.nlm.nih.gov/35898251
https://pubmed.ncbi.nlm.nih.gov/35898251
Publikováno v:
Seminars in Respiratory and Critical Care Medicine. 43:125-130
Effective antimicrobial therapy remains paramount to successful treatment of patients with critical illness, such as pneumonia and sepsis. Unfortunately, critically ill patients often exhibit altered pharmacokinetics and pharmacodynamics (PK/PD) that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddaa05fffefd94fd85880cb60c22341d
https://doi.org/10.1055/s-0041-1740972
https://doi.org/10.1055/s-0041-1740972
Autor:
Andrew F. Shorr, Andrew P. Michelson, Jean-François Timsit, Marin H. Kollef, José Garnacho-Montero, Matteo Bassetti, Scott T. Micek
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-10 (2021)
Critical Care
Critical Care
Severe or life threatening infections are common among patients in the intensive care unit (ICU). Most infections in the ICU are bacterial or fungal in origin and require antimicrobial therapy for clinical resolution. Antibiotics are the cornerstone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17751fc74c45665c54c5c1ed25904889
https://doaj.org/article/917bc16420fc474f9a1d9d1c0abe9634
https://doaj.org/article/917bc16420fc474f9a1d9d1c0abe9634